We are studying a new treatment called DZR123 for patients with advanced solid tumors and lymphomas. The trial will help us understand its safety and how well it works alone and with another medication.
Health conditions and diseases that the clinical trial is designed to study and treat.
Advanced solid tumors and lymphomas refer to various types of cancers that have progressed to an advanced stage, including urothelial carcinoma, ovarian carcinoma, endometrial cancer, and castration-resistant prostate cancer. These conditions can be aggressive and may require specialized treatment.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
